During the past decade, Dean Foundation conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dean Foundation" #1 sponsor was "Shire" with 4 trials, followed by "Cephalon" with 2 trials sponsored, "Otsuka Pharmaceutical Development & Commercialization, Inc." with 2 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored and "Ocera Therapeutics" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

According to Clinical.Site data, the most researched conditions in "Dean Foundation" are "Crohn's Disease" (2 trials), "Major Depressive Disorder" (2 trials), "Adult Attention Deficit Hyperactivity Disorder" (1 trials), "Alzheimer Disease" (1 trials) and "Anxiety Disorder" (1 trials). Many other conditions were trialed in "Dean Foundation" in a lesser frequency.

Most popular intervention types in "Dean Foundation" are "Drug" (14 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "ADT" (2 trials), "Gabitril" (2 trials), "OPC-34712" (2 trials) and "ALX-0600" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dean Foundation" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Dean Foundation". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Dean Foundation, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Dean Foundation, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".